Biotech Stock Heads For Major Resistance Level – Will It Reject?

While today’s potential trade my not have the option liquidity to make for a good trade, it still highlights a very important lesson for when looking for support and resistance levels. One very common scenario that takes place in trading is when a former level of support is broken and then acts as resistance. The opposite is also true.

When levels of resistance are broken, they very often will turn into support levels in the move is valid. This gives a very good jumping off point when finding our levels and brings us to today’s setup quite nicely.

As you will see in the video below, Denali Therapeutics (DNLI) established a pretty strong level of support over the past few months, failing to go much lower than this mark several times. Now, it appears set to rally back to that mark.

This scenario setups the stage for a possible reject of this $26 level. However, this is also somewhere you would like to practice your patience as the stock could very easily push past this level of resistance on strong buying volume. Focusing on price action at this level will help you get a feel for where the stock is headed.

If you are thinking reject, wait for an initial reject, followed by a retest to go higher. An additional failed attempt to push higher would add confirmation to weakness at this price overall. As always, cash is a position and there is no reason to force trades, the market will be there tomorrow… well, Monday, technically.

Learn to trade when you join The Profit Machine. There, you’ll learn all about my favorite stocks, setups, strategies, and plenty more. You’ll also be invited to weekly webinars where I answer questions and go over important trading lessons, like the one in today’s article. The best part, you’ll also receive live trade alerts. Not only will you get a world-class education, but you’ll earn while you learn.